At a glance
$78k
Retained + incremental revenue
$-1177904 vs Q2
Target $950k–1.05M
86.5%
Response time SLA
Target 80–85%
$56k
Retained revenue
$-937723 vs Q2
$22k
Sales gross revenue
Target $300–350k
4.4%
Lead to close
Target 1.6–1.75%
76.5%
CV Meds spent %
Target 65%
N/A
First rebill
Target 75%
N/A
Second rebill
Target 50%
71.4%
Shipping SLA %
Target 75%
15.5%
Cohort refund rate
Target ≤15%
4.46
Blended reputation
Target 4.5–4.6 · 192 reviews
$6.41
Total cost per contact
COGS + S&M ÷ contacts QTD
$10.06
Revenue per contact
Q3 QTD revenue ÷ total contacts Q3 QTD
$129k
Revenue per FH FTE
Run-rate (QTD rev ÷ days × 90) ÷ 7 FTEs · Target $172k/qtr
Detail
AreaMetricQ3 QTDQ2 Final
SalesGross revenue$22k$262k
SalesLead to close4.4%1.6%
RetentionRetained revenue$56k$994k
RetentionFirst rebillN/A49.0%
PartnershipsCV Meds spent %76.5%N/A
PartnershipsAlto SLA71.4%71.9%
Customer serviceCohort refund15.5%25.6%
Customer serviceCohort voided20.5%14.1%
Customer serviceResponse SLA86.5%85.6%
Customer serviceBlended reputation4.464.37
Initiative highlights v2
No initiative updates this week. Managers can post in #cx-partnerships-lt using [Sales], [Retention], [Partnerships], or [CX] to surface callouts here.
Heroes
$22k
Gross revenue QTD
Pacing $257k EOQ · Target $300–350k
4.4%
Lead to close
Target 1.6–1.75%
474.7%
Coverage rate
Target 100%
1.8%
Contact rate
Target 6–8%
$3.04
S&M cost per contact
S&M spend ÷ contacts QTD
No updates this week. Post in #cx-partnerships-lt starting with [Sales] to add one here.
Detail metrics
MetricQ3 QTDQ2Target
Gross revenue$22k$262k$300–350k
Lead to close4.4%1.6%1.6–1.75%
Coverage rate474.7%121.1%100%
Conversion rate50.4%25.9%27–29%
Contact rate1.8%5.0%6–8%
AOV$366$261
Monthly revenue (2026 YTD)
Gross Revenue — monthly waterfall ($k)  * Jul partial (Q3 QTD)
Weekly trends (YTD)
Gross Revenue ($k)
Lead to Close (%)
Contact Rate (%)
Outreach timing & contact types
How We Follow Up: Outreach Timing & Contact Types
Every lead moves through five timed stages of outbound contact — and can reach us directly at any point along the way
STAGE 1
Day 1
PRE SMS
CALL
POST SMS
EMAIL
4 touches
Opening & discovery, plus
email to purchase now
STAGE 2
Days 3–7
CALL
SMS
2 touches
Pivot to program value
(nutrition, fitness, clinician access)
STAGE 3
Days 10–14
VOICEMAIL
SMS
2 touches
Re-spark the prospect's
personal health goals
STAGE 4
Days 15–21
VOICEMAIL
SMS
2 touches
Low-pressure check-in,
acknowledging the time gap
STAGE 5
Day 22+
SMS
1 touch
Permission-to-close:
respectful sign-off
prospect can respond, call, or self-schedule at any of these points
REACHABLE THE ENTIRE TIME
The post-lead PDF and every transactional email include a schedule-a-call link and our sales phone number — so a prospect can book time or call in on their own schedule, independent of where they sit in the stages above.
As part of Stage 1, we also send every customer a distinct purchase link for 3-month bundles, giving them a direct path to buy without waiting for a call.
SCHEDULE-A-CALL LINK
SALES PHONE NUMBER
3-MONTH BUNDLE PURCHASE LINK (STAGE 1)
FuturHealth · Sales & Lead Strategy Overview · 2026
Heroes
$56k
Retained revenue QTD
Pacing $643k EOQ · Target $650–700k
N/A
First rebill retention
Target 75%
N/A
Second rebill
Target 50%
3.4%
Save %
Saved ÷ Cancel-reason tickets
$3.04
S&M cost per contact
S&M spend ÷ contacts QTD
No updates this week. Post in #cx-partnerships-lt starting with [Retention] to add one here.
Detail metrics
MetricQ3 QTDQ2Target
Retained revenue$56k$994k$650–700k
Customers saved11523
Avg revenue per save$5k$2k
Save %3.4%7.5%Evolving
↳ Cancel-reason tickets QTD3257,010
First rebill retentionN/A49.0%55%
Second rebill retentionN/A30.8%50%
Save rate trend (weekly, YTD)
Weekly save rate trend will appear here once the retained revenue CSV (WBR - Retained Revenue) has been processed with the updated parse script.
Recurring revenue waterfall — by save cohort
Each row is a cohort of customers saved in that month. Each column is a billing month. Values show estimated revenue collected in that period, distributed proportionally across each billing date. Blue columns = Q2 2026.
Save Cohort # Oct '24 Nov '24 Dec '24 Jan '25 Feb '25 Mar '25 Apr '25 May '25 Jun '25 Jul '25 Aug '25 Sep '25 Oct '25 Nov '25 Dec '25 Jan '26 Feb '26 Mar '26 Apr '26 May '26 Jun '26 Jul '26
Oct '24$69k$75k$57k$49k$44k$34k$31k$28k$27k$25k$21k$18k$17k$14k$16k$12k$10k$9k$8k$9k$8k$1k
Nov '24$132k$112k$94k$78k$71k$54k$53k$44k$39k$34k$34k$28k$25k$21k$20k$16k$15k$13k$12k$10k$4k
Dec '24$87k$84k$64k$52k$42k$31k$27k$23k$22k$20k$18k$16k$16k$13k$9k$8k$8k$7k$6k$1k
Jan '25$104k$94k$74k$58k$46k$42k$34k$32k$28k$24k$23k$20k$22k$16k$15k$14k$12k$11k$4k
Feb '25$80k$85k$72k$59k$47k$39k$34k$29k$27k$25k$21k$19k$16k$14k$11k$9k$9k$1k
Mar '25$86k$96k$82k$66k$57k$49k$44k$38k$33k$29k$27k$22k$23k$17k$15k$16k$2k
Apr '25$81k$84k$67k$54k$48k$37k$29k$25k$24k$19k$16k$15k$13k$10k$8k$1k
May '25$68k$71k$62k$46k$37k$34k$28k$23k$22k$19k$17k$13k$10k$8k$2k
Jun '25$55k$74k$60k$48k$38k$33k$25k$20k$18k$15k$13k$13k$10k$3k
Jul '25$100k$130k$100k$86k$70k$55k$44k$35k$31k$28k$23k$21k$5k
Aug '25$111k$151k$119k$93k$74k$50k$40k$37k$29k$25k$23k$4k
Sep '25$91k$102k$83k$67k$52k$38k$28k$27k$25k$21k$3k
Oct '25$59k$64k$60k$43k$37k$29k$26k$20k$17k$3k
Nov '25$37k$50k$48k$34k$30k$28k$21k$17k$3k
Dec '25$24k$28k$24k$20k$17k$14k$15k$2k
Jan '26$22k$31k$28k$24k$23k$19k$4k
Feb '26$22k$40k$36k$28k$21k$6k
Mar '26$19k$29k$22k$18k$2k
Apr '26$21k$22k$18k$3k
May '26$7k$13k$3k
Jun '26$5k$2k
Jul '26
Total $69k$207k$256k$331k$360k$401k$435k$450k$446k$506k$587k$637k$621k$571k$525k$461k$405k$391k$374k$326k$293k$56k
Low revenue High revenue Before save date
Heroes
76.5%
CV Meds spent %
Target 65%
71.4%
Shipping SLA %
Target 75%
97.8%
Meds Shipped %
Target 95%
89.8%
Meds Delivered %
Target 90%
No updates this week. Post in #cx-partnerships-lt starting with [Partnerships] to add one here.
Weekly trends
CV Meds spent % (weekly, CareValidate)
First rebill % by MSO (weekly, mature cohorts)
Second rebill % by MSO (weekly, mature cohorts)
Alto pharmacy shipped % (by cohort week, ≤5 days)
Alto pharmacy delivered % (by cohort week, ≤7 days)
Detail metrics
MSO / AreaMetricQ3 QTDQ2Target
CAREVALIDATE
CareValidate Meds spent76.5%N/A65–70%
Account creation87.8%N/A95%+
First rebillN/A48.9%55%
Cohort refund12.8%11.4%≤15%
Cohort voided20.9%20.5%≤16%
BBB complaints01
OPENLOOP
OpenLoop Meds spent42.6%55.7%65–70%
Account creation84.0%90.3%95%+
First rebillN/A56.2%55%
Cohort refund22.4%23.0%≤15%
Cohort voided13.4%15.1%≤16%
BBB complaints014
STEADYMD
SteadyMD First rebillN/A46.5%55%
Cohort refund18.2%≤15%
Cohort voided22.1%≤16%
BBB complaints01
ALTO PHARMACY
Alto pharmacy Shipping SLA % (≤3 days)71.4%71.9%75%
Meds Shipped % (≤5 days)97.8%96.6%95%
Meds Delivered % (≤7 days)89.8%78.7%90%
By medication (SLA)75%
Heroes
$3.37
COGS per contact
COGS spend ÷ contacts QTD
86.5%
Blended SLA
Target 80–85%
15.5%
Cohort refund
Target ≤15%
20.5%
Cohort voided
Target ≤16%
4.46
Blended reputation
4.5–4.6 range
No updates this week. Post in #cx-partnerships-lt starting with [CX] to add one here.
Metrics
Queue / SourceMetricQ3 QTDQ2Target
VOLUME
Total contacts QTD7,776165,288
↳ Cancel-reason tickets QTD3257,010
Voice AI self-service rate11.8%12.2%12–16%
BBB complaints QTD016
CCR QUEUE
CCRPhone SLA90.5%89.8%80–85%
CCRChat SLA90.2%92.9%80–85%
CCREmail SLA43.4%75.9%80–85%
CCRPhone AHT8.3 min8.8 min≤10 min
CCRChat AHT13.1 min39.5 min≤30 min
CRA QUEUE
CRAPhone SLA92.1%95.1%80–85%
CRAChat SLA89.8%87.2%80–85%
CRAEmail SLA100.0%98.3%80–85%
CRAPhone AHT8.2 min9.6 min≤10 min
CRAChat AHTN/A36.4 min≤30 min
REPUTATION
Blended (TP + FH+ App) (192 reviews)4.464.374.5–4.6
Trustpilot (51 reviews)4.244.41
FH+ Apple App Store (129 reviews)4.624.13
FH+ Google Play Store (12 reviews)3.674.00
Legacy Apple (deprecated) (56 reviews)4.274.54
Legacy Google (deprecated) (6 reviews)2.333.43